Abstract
The aim of the paper was to apply a method for quantitative assessment of proliferation and apoptosis markers, based on their 3D visualization, in cases of parathyroid adenoma and hyperplasia. Material was obtained from 49 patients (32 females and 17 males) with primary hyperparahyroidism. Quantitative immunohistochemistry studies of Ki-67, proliferating cell nuclear antigen (PCNA) and bcl-2 were performed on digital microscopy images with the use of 3D visualization. The use of spatial visualization method allowed us to perform objective quantitative assessment of the studied immunohistochemical markers. The average cell nuclear fraction of Ki67+ was 1.8% in hyperplasia and 1.9% in adenoma cases while 3.5% in the controls. The highest expression of PCNA was found in parathyroid hyperplasia (22.9%) and significantly decreased in adenoma (12.5%) and in the control group (16.8%). The lower expression of bcl-2 in hyperplasia cases (mean area fraction of 0.172 per 1 μm2, in contrast to 0.643 in adenomas and 0.648 in control) suggested that principal cells can be ready for apoptosis and may confirm the important role of bcl-2 protein in etiopathogenesis of hyperplasia of the parathyroid gland while PCNA might be a useful marker for differentiating adenoma from early hyperplasia in primary hyperparahyroidism cases.
Similar content being viewed by others
References
Abbona GC, Papotti M, Gasparri G et al (1995) Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 26:135–138. doi:10.1016/0046-8177(95)90028-4
Alo PL, Mazzaferro VP, Eleuteri S, Serpieri D, Mangoni A, Botti C et al (1999) Immunohistochemical study of fatty acid synthase, Ki67, proliferating cell nuclear antigen, and p53 in hyperplastic parathyroids expression. Ann Diagn Pathol 3:287–293. doi:10.1016/S1092-9134(99)80024-0
Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8:135–160. doi:10.1191/096228099673819272
Brandi ML, Falchetti A (2004) Genetics of primary hyperparathyroidism. Urol Int 72(Suppl 1):11–16. doi:10.1159/000076584
Dahab GM, Kheriza MM, El-Beltagi HM, Fouda A-MM, Sharaf El-Din OA (2004) Digital quantification of fibrosis in liver biopsy sections: description of a new method by Photoshop software. J Gastroenterol Hepatol 19(1):78–85
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188. doi:10.1016/0197-2456(86)90046-2
Diallo JS, Aldejmah A, Mouhim AF, Peant B, Fahmy MA, Koumakpayi IH et al (2007) NOXA and PUMA expression add to clinicalmarkers in predicting biochemical recurrence of prostate cancer patients in a survival tree model. Clin Cancer Res 13(23):7044–7052. doi:10.1158/1078-0432.CCR-07-1224
Endl E, Gerdes J (2000) The Ki-67 protein: fascinating forms and an unknown function. Exp Cell Res 257:231–237. doi:10.1006/excr.2000.4888
Grimelius L, DeLellis RA, Bondeson L, Akerstrom G, Arnold A, Franssila KO, Hendy GN, Dupuy D, Eng C (2004) Parathyroid adenoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) World Health Organization classification of tumors, pathology and genetics tumors of endocrine origin. International Agency for Research on Cancer Press, Lyon, France, pp 128–132
Hadar TSJ, Yaniv E, Ram E, Shvili I, Koren R (2005) Expression of p53, Ki-67 and Bcl-2 in parathyroid adenoma and residual normal tissue. Pathol Oncol Res 11:45–49
Hertig A, Maruani G, Paillard M, Houillier P (2000) Primary hyperparathyroidism. Nephrologie 21:283–290
Kaczmarek E, Strzelczyk R (2005) From two to three-dimensional visualisation of structures in light and confocal microscopy—applications for biomedical studies. In: Mendez-Vilas A, Labajos-Broncano L (eds) Current issues on multidisciplinary microscopy research and education. FORMATEX microscopy book series no. II. Formatex Research Centre, Badajoz, pp 289–295
Karak AK, Sarkar C, Chumber S, Tandon N (1997) MIB-1 proliferative index in parathyroid adenoma & hyperplasia. Indian J Med Res 105:235–238
Loda M, Lipman J, Cukor B, Bur M, Kwan P, DeLellis RA (1994) Nodular foci in parathyroid adenomas and hyperplasias: an immunohistochemical analysis of proliferative activity. Hum Pathol 25:1050–1056
Lehr HE, van der Loos CM, Teeling P, Gown AM (1999) Complete chromogen separation and analysis in double immunohistochemical stains using photoshop-based image analysis. J Histochem Cytochem 47:119–125
Maga G, Hubscher U (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 116:3051–3060
Naccarato AG, Marcocci C, Miccoli P, Bonadio AG, Cianferotti L, Vignali E, Cipollini G, Viacava P (1998) Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissues. J Endocrinol Invest 21:136–141
Ohta K, Manabe T, Katagiri M, Harada T (1994) Expression of proliferating cell nuclear antigens in parathyroid glands of renal hyperparathyroidism. World J Surg 18:625–628
Saggiorato E, Bergero N, Volante M, Bacillo E, Rosas R, Gasparri G, Orlandi F, Papotti M (2006) Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions. Am J Clin Pathol 126:59–66
Sont JK, de Boer WI, Annemarie W, van Schadewijk AM, Grunberg K, Han J, van Krieken JM, Hiemstra PS, Sterk PJ, The Asthma Management Project University of Leiden Study Group (2003) Fully automated assessment of inflammatory cell counts and cytokine expression in bronchial tissue. Am J Respir Crit Care Med 167:1496–1503
Stangl DK, Berry DA (2000) Meta-analysis in medicine and health policy. CRC Press, Boca Raton, FL
Szende B, Arvai K, Petak I, Nagy K, Vegso G, Perner F (2006) Changes in gne expression in the course of proliferative processes in the parathyroid gland. Magy Onkol 50:137–140
Wang W, Johansson H, Kvasnicka T et al (1996) Detection of apoptotic cells and expression of Ki-67 antigen, Bcl-2, p53 oncoproteins in human parathyroid adenoma. APMIS 104:789–796
Yamaguchi S, Yachiku S, Morikawa M (1997) Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism. J Clin Endocrinol Metab 82:2681–2688
Zhang P, Duchambon P, Gogusev J, Nabarra B, Sarfati E, Bourdeau A, Drüeke TB (2000) Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism. Kidney Int 57:437–445
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaczmarek, E., Lacka, K., Majewski, P. et al. Selected markers of proliferation and apoptosis in the parathyroid lesions: a spatial visualization and quantification. J Mol Hist 39, 509–517 (2008). https://doi.org/10.1007/s10735-008-9190-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-008-9190-1